169 related articles for article (PubMed ID: 6181328)
1. Dissociation of antiplatelet effects from myocardial cytoprotective activity during acute myocardial ischemia in cats by a new carbacyclin derivative (ZK 36 375).
Schrör K; Darius H; Ohlendorf R; Matzky R; Klaus W
J Cardiovasc Pharmacol; 1982; 4(4):554-61. PubMed ID: 6181328
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of a new carbacyclin derivative, ZK 36 374, in acute myocardial ischemia.
Schrör K; Ohlendorf R; Darius H
J Pharmacol Exp Ther; 1981 Oct; 219(1):243-9. PubMed ID: 6169823
[TBL] [Abstract][Full Text] [Related]
3. The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374)--equipotent to PGI2 in vitro.
Schrör K; Darius H; Matzky R; Ohlendorf R
Naunyn Schmiedebergs Arch Pharmacol; 1981 Jun; 316(3):252-5. PubMed ID: 6166877
[No Abstract] [Full Text] [Related]
4. Early and late administration of a PGI2-analogue, ZK 36 374 (iloprost): effects on myocardial preservation, collateral blood flow and infarct size.
Smith EF; Gallenkämper W; Beckmann R; Thomsen T; Mannesmann G; Schrör K
Cardiovasc Res; 1984 Mar; 18(3):163-73. PubMed ID: 6200229
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion.
Johnson G; Tsao PS; Mulloy D; Lefer AM
J Pharmacol Exp Ther; 1990 Jan; 252(1):35-41. PubMed ID: 2153807
[TBL] [Abstract][Full Text] [Related]
6. Beneficial actions of the thromboxane receptor antagonist, AH-23,848, in acute myocardial ischemia.
Brezinski ME; Osborne JA; Yanagisawa A; Lefer AM
Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):703-9. PubMed ID: 2966270
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective action of the new stable epoprostenol analogue CG 4203 in rat models of cardiac hypoxia and ischemia.
Müller B; Schneider J; Hennies HH; Flohé L
Arzneimittelforschung; 1984; 34(11):1506-9. PubMed ID: 6441579
[TBL] [Abstract][Full Text] [Related]
8. Effects of prostacyclin and of the stable prostacyclin analogue ZK 36374 on forearm blood flow and blood platelet behaviour in man.
Cowley AJ; Heptinstall S; Hampton JR
Thromb Haemost; 1985 Feb; 53(1):90-4. PubMed ID: 2581332
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective actions of a new calcium channel blocker in acute myocardial ischemia.
Brezinski ME; Darius H; Lefer AM
Arzneimittelforschung; 1986 Mar; 36(3):464-6. PubMed ID: 3707665
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular actions in vitro and cardioprotective effects in vivo of nileprost, a mixed type PGI2/PGE2 agonist.
Darius H; Thomsen T; Schrör K
J Cardiovasc Pharmacol; 1987 Aug; 10(2):144-52. PubMed ID: 2441164
[TBL] [Abstract][Full Text] [Related]
11. Control of human and animal platelet aggregation by a new prostacyclin analog.
Maderna P; Colli S; Sirtori C; Tremoli E; Paoletti R
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():363-9. PubMed ID: 2408447
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of the deleterious effects of platelets activated during cardiopulmonary bypass. Comparison of a thromboxane synthetase inhibitor and a prostacyclin analogue.
Huddleston CB; Hammon JW; Wareing TH; Lupinetti FM; Clanton JA; Collins JC; Bender HW
J Thorac Cardiovasc Surg; 1985 Feb; 89(2):190-5. PubMed ID: 2578591
[TBL] [Abstract][Full Text] [Related]
13. (5Z)-carbacyclin displays agonist-antagonist properties on prostacyclin-receptors in platelets and vascular myocytes.
Corsini A; Oliva D; Folco GC; Giovanazzi S; Noe' MA; Fumagalli R; Nicosia S
Biomed Biochim Acta; 1988; 47(10-11):S104-7. PubMed ID: 3073757
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the vasodepressor action of ZK 36 374, a stable prostacyclin derivative, PGI2 and PGE1 with their effect on platelet aggregation and bleeding time in rats.
Casals-Stenzel J; Buse M; Losert W
Prostaglandins Leukot Med; 1983 Feb; 10(2):197-212. PubMed ID: 6189133
[TBL] [Abstract][Full Text] [Related]
15. Studies on the protective effect of prostacyclin in acute myocardial ischemia.
Ogletree ML; Lefer AM; Smith JB; Nicolaou KC
Eur J Pharmacol; 1979 Jun; 56(1-2):95-103. PubMed ID: 467518
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological properties of the new stable prostacyclin analogue 3-Oxa-methano-prostaglandin I.
Yamamoto T; Satoh K; Nishimura T; Horikawa N; Mine T; Hirohashi T; Hara Y
Arzneimittelforschung; 1994 Apr; 44(4):483-90. PubMed ID: 8011001
[TBL] [Abstract][Full Text] [Related]
17. The effect of the stable prostacyclin analogue ZK 36374 on experimental coronary thrombosis in the pig.
van der Giessen WJ; Mooi WJ; Rutteman AM; Berk L; Verdouw PD
Thromb Res; 1984 Oct; 36(1):45-51. PubMed ID: 6209820
[TBL] [Abstract][Full Text] [Related]
18. Endothelium and myocardial protecting actions of taprostene, a stable prostacyclin analogue, after acute myocardial ischemia and reperfusion in cats.
Johnson G; Furlan LE; Aoki N; Lefer AM
Circ Res; 1990 May; 66(5):1362-70. PubMed ID: 2159389
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of oxygen-centered free radical formation by the stable prostacyclin-mimetic iloprost (ZK 36 374) in acute myocardial ischemia.
Thiemermann C; Steinhagen-Thiessen E; Schrör K
J Cardiovasc Pharmacol; 1984; 6(2):365-6. PubMed ID: 6200730
[No Abstract] [Full Text] [Related]
20. Delayed antiischemic effect of prostaglandin I2 and of a new stable prostaglandin I2 analogue, 7-oxo-prostacyclin-Na, in experimental model angina in dogs.
Szekeres L; Krassói I; Pataricza J; Udvary E
Adv Myocardiol; 1985; 6():607-18. PubMed ID: 3887531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
